ELANE gene mutation related cyclic neutropenia with childhood systemic lupus erythematosus: a case report
DOI:
https://doi.org/10.18203/2349-3291.ijcp20242032Keywords:
Cyclic neutropenia, Juvenile systemic lupus erythematosus, ELANE gene mutation, Recurrent infectionAbstract
ELANE related neutropenia includes congenital and cyclic neutropenia which are primary haematological disorders characterised by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis). A congenital cyclic neutropenia syndrome is a rare genetic disorder characterised by a cyclic reduction in the granulocyte proliferation pool in the bone marrow followed by the onset of neutropenia. Patients suffering from this disorder are susceptible to infections and clinically presents at early age. Patients having ELANE mutation combined with autoimmune diseases may have recurrent infections. This was a case report of a 3-year and 6-month-old female child presenting with recurrent pneumonia and oral ulcer. She had ELANE gene mutation associated cyclic neutropenia and was later diagnosed with childhood-onset systemic lupus erythematosus. Hence, it is important to identify rare causes of immunosuppressive conditions in children presenting with recurrent infections to prevent several long-term complications.
Metrics
References
Patil VH, Hugar SM, Balikai G, Patil S. Severe congenital cyclic neutropenia: a case report. Int J Appl Basic Med Res. 2016;6(4):293-6.
Boxer LA. Severe congenital neutropenia: genetics and pathogenesis. Transac Am Clin Climatolog Assoc. 2006;117:13.
Wang J, Zhang H, Wang Y, Liang L, Yang Z. Severe congenital neutropenia caused by ELANE gene mutation: a case report and literature review. Medicine. 2022;101(44):31357.
Zhang D, Su G, Hao S, Lai J, Feng S. Pediatric autoimmune diseases with ELANE gene mutation associated with neutropenia. Pediatr Rheumatol Online J. 2023;21:41.
Nakai Y, Ishihara C, Ogata S, Shimono T. Oral manifestations of cyclic neutropenia in a Japanese child: case report with a 5-year follow-up. Pediatr Dentist. 2003;25(4):383-8.
Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood J Am Soc Hematol. 2000;96(7):2317-22.
Bellanné-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood. 2004;103(11):4119-25.
Charras AM, Smith E, Hedrich CM. Systemic lupus erythematosus in children and young people. Curr Rheumatol Rep. 2023;23:1-5.
Liu Y, Kaplan MJ. Cardiovascular disease in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(5):441-8.
Tsokos GC, Lo MS, Reis PC, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nature Rev Rheumatol. 2016;12(12):716-30.
Katsiari CG, Liossis SN, Sfikakis PP. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthrit Rheumat. 2010;39(6):491-503.
Oke V, Gunnarsson I, Dorschner J, Eketjäll S, Zickert A, Niewold TB, et al. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthrit Res Ther. 2019;21:1.